BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38160788)

  • 1. Identification of SRSF10 as a promising prognostic biomarker with functional significance among SRSFs for glioma.
    An W; Yang Q; Xi Y; Pan H; Huang H; Chen Q; Wang Y; Hua D; Shi C; Wang Q; Sun C; Luo W; Li X; Yu S; Zhou X
    Life Sci; 2024 Feb; 338():122392. PubMed ID: 38160788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SRSF10 facilitates HCC growth and metastasis by suppressing CD8
    Luo X; Zhang Z; Li S; Wang Y; Sun M; Hu D; Jiang J; Wang Y; Ji X; Chen X; Zhang B; Liang H; Li Y; Liu B; Xu X; Wang S; Xu S; Nie Y; Wu K; Fan D; Liu D; Huang W; Xia L
    Int Immunopharmacol; 2024 Jan; 127():111376. PubMed ID: 38113691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splicing factor-mediated regulation patterns reveals biological characteristics and aid in predicting prognosis in acute myeloid leukemia.
    Zhong FM; Yao FY; Liu J; Li MY; Jiang JY; Cheng Y; Xu S; Li SQ; Zhang N; Huang B; Wang XZ
    J Transl Med; 2023 Jan; 21(1):6. PubMed ID: 36611187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SRSF10 inhibits biogenesis of circ-ATXN1 to regulate glioma angiogenesis via miR-526b-3p/MMP2 pathway.
    Liu X; Shen S; Zhu L; Su R; Zheng J; Ruan X; Shao L; Wang D; Yang C; Liu Y
    J Exp Clin Cancer Res; 2020 Jun; 39(1):121. PubMed ID: 32600379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SRSF5: a novel marker for small-cell lung cancer and pleural metastatic cancer.
    Kim HR; Lee GO; Choi KH; Kim DK; Ryu JS; Hwang KE; Na KJ; Choi C; Kuh JH; Chung MJ; Lee MK; So HS; Yoon KH; Park MC; Na KS; Kim YS; Park DS
    Lung Cancer; 2016 Sep; 99():57-65. PubMed ID: 27565915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The aberrant upregulation of exon 10-inclusive SREK1 through SRSF10 acts as an oncogenic driver in human hepatocellular carcinoma.
    Chang C; Rajasekaran M; Qiao Y; Dong H; Wang Y; Xia H; Deivasigamani A; Wu M; Sekar K; Gao H; Sun M; Niu Y; Li Q; Tao L; Yan Z; Wang M; Chen S; Zhao S; Chen D; Li L; Yang F; Gao H; Chen B; Su L; Xu L; Chen Y; Seshachalam VP; Chen G; Gunaratne J; Hong W; Shi J; Chen G; Grierson DS; Chabot B; Xie T; Hui KM; Chen J
    Nat Commun; 2022 Mar; 13(1):1363. PubMed ID: 35296659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SRSF10 stabilizes CDC25A by triggering exon 6 skipping to promote hepatocarcinogenesis.
    Liu X; Zheng Y; Xiao M; Chen X; Zhu Y; Xu C; Wang F; Liu Z; Cao K
    J Exp Clin Cancer Res; 2022 Dec; 41(1):353. PubMed ID: 36539837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
    Tian QS; Zhang Q; Huang W
    Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SRSF10: an atypical splicing regulator with critical roles in stress response, organ development, and viral replication.
    Shkreta L; Delannoy A; Salvetti A; Chabot B
    RNA; 2021 Nov; 27(11):1302-1317. PubMed ID: 34315816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bioinformatics Analysis and Preliminary Functional Study of Abnormal Expression of Splicing Factors in Gastric Cancer].
    Zhang A; Shi J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Jun; 42(3):289-296. PubMed ID: 32616122
    [No Abstract]   [Full Text] [Related]  

  • 11. BCLAF1 and its splicing regulator SRSF10 regulate the tumorigenic potential of colon cancer cells.
    Zhou X; Li X; Cheng Y; Wu W; Xie Z; Xi Q; Han J; Wu G; Fang J; Feng Y
    Nat Commun; 2014 Aug; 5():4581. PubMed ID: 25091051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of SRSF10 as a regulator of SMN2 ISS-N1.
    Frederiksen SB; Holm LL; Larsen MR; Doktor TK; Andersen HS; Hastings ML; Hua Y; Krainer AR; Andresen BS
    Hum Mutat; 2021 Mar; 42(3):246-260. PubMed ID: 33300159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discovery.
    Blázquez-Encinas R; García-Vioque V; Caro-Cuenca T; Moreno-Montilla MT; Mangili F; Alors-Pérez E; Ventura S; Herrera-Martínez AD; Moreno-Casado P; Calzado MA; Salvatierra Á; Gálvez-Moreno MA; Fernandez-Cuesta L; Foll M; Luque RM; Alcala N; Pedraza-Arevalo S; Ibáñez-Costa A; Castaño JP
    J Transl Med; 2023 Dec; 21(1):879. PubMed ID: 38049848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGIF2 is a potential biomarker for diagnosis and prognosis of glioma.
    Zhang W; Zhang L; Dong H; Peng H
    Front Immunol; 2024; 15():1356833. PubMed ID: 38629068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SRSF10 is essential for progenitor spermatogonia expansion by regulating alternative splicing.
    Liu W; Lu X; Zhao ZH; Su R; Li QL; Xue Y; Gao Z; Sun SS; Lei WL; Li L; An G; Liu H; Han Z; Ouyang YC; Hou Y; Wang ZB; Sun QY; Liu J
    Elife; 2022 Nov; 11():. PubMed ID: 36355419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Srsf10 and the minor spliceosome control tissue-specific and dynamic SR protein expression.
    Meinke S; Goldammer G; Weber AI; Tarabykin V; Neumann A; Preussner M; Heyd F
    Elife; 2020 Apr; 9():. PubMed ID: 32338600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
    Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
    Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Expression of CKS2 Predicts Adverse Outcomes: A Potential Therapeutic Target for Glioma.
    Yu K; Ji Y; Liu M; Shen F; Xiong X; Gu L; Lu T; Ye Y; Feng S; He J
    Front Immunol; 2022; 13():881453. PubMed ID: 35663965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SRSF10 Plays a Role in Myoblast Differentiation and Glucose Production via Regulation of Alternative Splicing.
    Wei N; Cheng Y; Wang Z; Liu Y; Luo C; Liu L; Chen L; Xie Z; Lu Y; Feng Y
    Cell Rep; 2015 Nov; 13(8):1647-57. PubMed ID: 26586428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CASH: a constructing comprehensive splice site method for detecting alternative splicing events.
    Wu W; Zong J; Wei N; Cheng J; Zhou X; Cheng Y; Chen D; Guo Q; Zhang B; Feng Y
    Brief Bioinform; 2018 Sep; 19(5):905-917. PubMed ID: 28387786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.